Joint Opinion on antimicrobial resistance (AMR) focused on zoonotic infections

EFSA Journal

Volumn 7, Issue 11, 2009, Pages

[No Author Info available]

Author keywords

Antimicrobial resistance; biocides; Campylobacter; cephalosporins; E. coli; emerging risks; foodborne zoonoses; macrolides; MRSA; multidrug resistance; quinolones; Salmonella; usage of antimicrobials; veterinary medicines

Indexed keywords

EID: 77956938823     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2009.1372     Document Type: Article

References (163)

1. Aarestrup FM, Hasman H, Agerso Y, Jensen LB, Harksen S and Svensmark B, 2006. First description of blaCTX-M-1-carrying Escherichia coli isolates in Danish primary food production. J Antimicrob Chemother 57 (6), 1258–1259.
2. Acke E, McGill K, Golden O, Jones BR, Fanning S and Whyte P, 2009. Prevalence of thermophilic Campylobacter species in household cats and dogs in Ireland. Vet Rec 164 (2), 44–47.
3. Acke E, McGill K, Quinn T, Jones BR, Fanning S and Whyte P, 2009. Antimicrobial resistance profiles and mechanisms of resistance in Campylobacter jejuni isolates from pets. Foodborne Pathog Dis 6 (6), 705–710.
4. Acke E, Whyte P, Jones BR, McGill K, Collins JD and Fanning S, 2006. Prevalence of thermophilic Campylobacter species in cats and dogs in two animal shelters in Ireland. Vet Rec 158 (2), 51–54.
5. Anon, 2009. Ongoing investigation into reptile-associated Salmonella infections. Health Protection Report 3 (14), 4.
6. Antunes P, Machado J and Peixe L, 2006. Characterization of antimicrobial resistance and class 1 and 2 integrons in Salmonella enterica isolates from different sources in Portugal. J Antimicrob Chemother 58 (2), 297–304.
7. Antunes P, Machado J, Sousa JC and Peixe L, 2004. Dissemination amongst humans and food products of animal origin of a Salmonella Typhimurium clone expressing an integron-borne OXA-30 beta-lactamase. J Antimicrob Chemother 54 (2), 429–434.
8. Antunes P, Matias R and Peixe L, 2009. Plasmid-mediated quinolone resistance in Salmonella isolates from different sources of Portugal. Clinical Microbiology and Infection 15 (Suppl 4), 411–412.
9. Arlet G, Barrett TJ, Butaye P, Cloeckaert A, Mulvey MR and White DG, 2006. Salmonella resistant to extended-spectrum cephalosporins: prevalence and epidemiology. Microbes Infect 8 (7), 1945–1954.
10. Bailey AM, Constantinidou C, Ivens A, Garvey MI, Webber MA, Coldham N, Hobman JL, Wain J, Woodward MJ and Piddock LJ, 2009. Exposure of Escherichia coli and Salmonella enterica serovar Typhimurium to triclosan induces a species-specific response, including drug detoxification. J Antimicrob Chemother 64 (5), 973–985.
11. Bardon J, Kolar M, Cekanova L, Hejnar P and Koukalova D, 2009. Prevalence of Campylobacter jejuni and its resistance to antibiotics in poultry in the Czech Republic. Zoonoses Public Health 56 (3), 111–116.
12. Barza M, 2002. Potential mechanisms of increased disease in humans from antimicrobial resistance in food animals. Clin Infect Dis 34 Suppl 3, S123–125.
13. Bass L, Liebert CA, Lee MD, Summers AO, White DG, Thayer SG and Maurer JJ, 1999. Incidence and characterization of integrons, genetic elements mediating multiple-drug resistance, in avian Escherichia coli. Antimicrob Agents Chemother 43 (12), 2925–2929.
14. Baucheron S, Imberechts H, Chaslus-Dancla E and Cloeckaert A, 2002. The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar typhimurium phage type DT204. Microb Drug Resist 8 (4), 281–289.
15. Bertrand S, Weill FX, Cloeckaert A, Vrints M, Mairiaux E, Praud K, Dierick K, Wildemauve C, Godard C, Butaye P, Imberechts H, Grimont PA and Collard JM, 2006. Clonal emergence of extended-spectrum beta-lactamase (CTX-M-2)-producing Salmonella enterica serovar Virchow isolates with reduced susceptibilities to ciprofloxacin among poultry and humans in Belgium and France (2000 to 2003). J Clin Microbiol 44 (8), 2897–2903.
16. Blanco JE, Blanco M, Mora A and Blanco J, 1997. Prevalence of bacterial resistance to quinolones and other antimicrobials among avian Escherichia coli strains isolated from septicemic and healthy chickens in Spain. J Clin Microbiol 35 (8), 2184–2185.
17. Bostan K, Aydin A and Ang MK, 2009. Prevalence and antibiotic susceptibility of thermophilic Campylobacter species on beef, mutton, and chicken carcasses in Istanbul, Turkey. Microb Drug Resist 15 (2), 143–149.
18. Cagliero C, Mouline C, Payot S and Cloeckaert A, 2005. Involvement of the CmeABC efflux pump in the macrolide resistance of Campylobacter coli. J Antimicrob Chemother 56 (5), 948–950.
19. Canton R, Novais A, Valverde A, Machado E, Peixe L, Baquero F and Coque TM, 2008. Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 14 Suppl 1, 144–153.
20. Carattoli A, 2009. Resistance plasmid families in Enterobacteriaceae. Antimicrob Agents Chemother 53 (6), 2227–2238.
21. Cattoir V, Weill FX, Poirel L, Fabre L, Soussy CJ and Nordmann P, 2007. Prevalence of qnr genes in Salmonella in France. J Antimicrob Chemother 59 (4), 751–754.
22. Cavaco LM, Hendriksen RS and Aarestrup FM, 2007. Plasmid-mediated quinolone resistance determinant qnrS1 detected in Salmonella enterica serovar Corvallis strains isolated in Denmark and Thailand. J Antimicrob Chemother 60 (3), 704–706.
23. CDC, 2001. Outbreaks of multidrug-resistant Salmonella Typhimurium associated with veterinary facilities: Idaho, Minnesota and Washington, 1999. Morbid Mortal Wkly Rep 50, 701–704.
24. Chiaretto G, Zavagnin P, Bettini F, Mancin M, Minorello C, Saccardin C and Ricci A, 2008. Extended spectrum beta-lactamase SHV-12-producing Salmonella from poultry. Vet Microbiol 128 (3–4), 406–413.
25. Cloeckaert A, Praud K, Doublet B, Bertini A, Carattoli A, Butaye P, Imberechts H, Bertrand S, Collard JM, Arlet G and Weill FX, 2007. Dissemination of an extended-spectrum-beta-lactamase blaTEM-52 gene-carrying IncI1 plasmid in various Salmonella enterica serovars isolated from poultry and humans in Belgium and France between 2001 and 2005. Antimicrob Agents Chemother 51 (5), 1872–1875.
26. Collignon P, Powers JH, Chiller TM, Aidara-Kane A and Aarestrup FM, 2009. World Health Organization ranking of antimicrobials according to their importance in human medicine: A critical step for developing risk management strategies for the use of antimicrobials in food production animals. Clin Infect Dis 49 (1), 132–141.
27. Corcoran D, Quinn T, Cotter L and Fanning S, 2005. Relative contribution of target gene mutation and efflux to varying quinolone resistance in Irish Campylobacter isolates. FEMS Microbiol Lett 253 (1), 39–46.
28. Corcoran D, Quinn T, Cotter L and Fanning S, 2006. An investigation of the molecular mechanisms contributing to high-level erythromycin resistance in Campylobacter. Int J Antimicrob Agents 27 (1), 40–45.
29. Cosgrove SE, 2006. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 42 Suppl 2, S82–89.
30. Cox LAJ and Popken DA, 2006. Quantifying potential human health impacts of animal antibiotic use: enrofloxacin and macrolides in chickens. Risk Anal 26 (1), 135–146.
31. Cremet L, Caroff N, Dauvergne S, Reynaud A, Lepelletier D and Corvec S, 2009. Prevalence of plasmid-mediated quinolone resistance determinants in ESBL Enterobacteriaceae clinical isolates over a 1-year period in a French hospital. Pathol Biol (Paris).
32. Crook PD, Aguilera JF, Threlfall EJ, O'Brien SJ, Sigmundsdottir G, Wilson D, Fisher IS, Ammon A, Briem H, Cowden JM, Locking ME, Tschape H, Van Pelt W, Ward LR and Widdowson MA, 2003. A European outbreak of Salmonella enterica serotype Typhimurium definitive phage type 204b in 2000. Clin Microbiol Infect 9 (8), 839–845.
33. CSSSC, 2002. Ciprofloxacin resistance in Campylobacter jejuni: case-case analysis as a tool for elucidating risks at home and abroad. J Antimicrob Chemother 50 (4), 561–568.
34. Damborg P, Olsen KE, Moller Nielsen E and Guardabassi L, 2004. Occurrence of Campylobacter jejuni in pets living with human patients infected with C. jejuni. J Clin Microbiol 42 (3), 1363–1364.
35. Danis K, Di Renzi M, O'Neill W, Smyth B, McKeown P, Foley B, Tohani V and Devine M, 2009. Risk factors for sporadic Campylobacter infection: an all-Ireland case-control study. Euro Surveill 14 (7).
36. DANMAP (2007). Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark.: www.danmap.org/pdfFILES/DANMAP_2007.pdf.
37. de Jong A, Bywater R, Butty P, Deroover E, Godinho K, Klein U, Marion H, Simjee S, Smets K, Thomas V, Valle M and Wheadon A, 2009. A pan-European survey of antimicrobial susceptibility towards human-use antimicrobial drugs among zoonotic and commensal enteric bacteria isolated from healthy food-producing animals. J Antimicrob Chemother 63 (4), 733–744.
38. Desenclos JC and Guillemot D, 2004. Consequences of bacterial resistance to antimicrobial agents. Emerg Infect Dis 10 (4), 759–760.
39. Devasia RA, Varma JK, Whichard J, Gettner S, Cronquist AB, Hurd S, Segler S, Smith K, Hoefer D, Shiferaw B, Angulo FJ and Jones TF, 2005. Antimicrobial use and outcomes in patients with multidrug-resistant and pansusceptible Salmonella Newport infections, 2002–2003. Microb Drug Resist 11 (4), 371–377.
40. Doorduyn Y, Van Pelt W, Siezen CL, Van Der Horst F, Van Duynhoven YT, Hoebee B and Janssen R, 2008. Novel insight in the association between salmonellosis or campylobacteriosis and chronic illness, and the role of host genetics in susceptibility to these diseases. Epidemiol Infect 136 (9), 1225–1234.
41. DuPont HL, 2007. The growing threat of foodborne bacterial enteropathogens of animal origin. Clin Infect Dis 45 (10), 1353–1361.
42. EFSA, 2006. The Community Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Antimicrobial resistance in the European Union in 2004 Available at: www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1178620772157.htm.
43. EFSA, 2007a. The Community summary report on trends and sources of zoonoses, zoonotic agents, antimicrobial resistance and foodborne outbreaks in the European Union in 2005. The EFSA Journal 94, 3–288. www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1178620767319.htm.
44. EFSA, 2007b. The Community summary report on trends and sources of zoonoses, zoonotic agents, antimicrobial resistance and foodborne outbreaks in the European Union in 2006. The EFSA Journal 130, 3–288. www.efsa.europa.eu/cs/BlobServer/DocumentSet/Zoon_report_2006_en,0.pdf?ssbinary=yrue.
45. EFSA, 2007c. Report including a proposal for a harmonized monitoring scheme of antimicrobial resistance in Salmonella in fowl (Gallus gallus), turkeys, and pigs and Campylobacter jejuni and C. coli in broilers. The EFSA Journal 96, 1–46. www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1178620761886.htm.
46. EFSA, 2008. Scientific Opinion of the Panel on Biological Hazards on a request from DG SANCO on the assessment of the possible effect of the four antimicrobial treatment substances on the emergence of antimicrobial resistance. The EFSA Journal 659, 1–26. www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1178697425124.htm.
47. EFSA, 2009. Summary report on information on antimicrobial resistance in zoonotic agents isolated from food and animals from years 2004–2007 in the EU. The EFSA Journal 7 (11).
48. EMEA, 2009. Revised reflection paper on the use of 3rd and 4th generation cephalosporins in food producing animals in the European Union: development of resistance and impact on human and animal health. www.emea.europa.eu/pdfs/vet/sagam/8173006enfin.pdf.
49. Endtz HP, Ruijs GJ, Van Klingeren B, Jansen WH, Van Der Reyden T and Mouton RP, 1991. Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J Antimicrob Chemother 27 (2), 199–208.
50. Engberg J, Aarestrup FM, Taylor DE, Gerner-Smidt P and Nachamkin I, 2001. Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg Infect Dis 7 (1), 24–34.
51. Engberg J, Neimann J, Nielsen EM, Aerestrup FM and Fussing V, 2004. Quinolone-resistant Campylobacter infections: risk factors and clinical consequences. Emerg Infect Dis 10 (6), 1056–1063.
52. Erskine RJ, Bartlett PC, VanLente JL and Phipps CR, 2002. Efficacy of systemic ceftiofur as a therapy for severe clinical mastitis in dairy cattle. J Dairy Sci 85 (10), 2571–2575.
53. ESAC. 2009. ESAC Yearbook 2007. Antwerp, Belgium, University of Antwerp app.esac.ua.ac.be/public/index.php/en_gb.
54. Gaudreau C and Gilbert H, 2003. Antimicrobial resistance of Campylobacter jejuni subsp. jejuni strains isolated from humans in 1998 to 2001 in Montreal, Canada. Antimicrob Agents Chemother 47 (6), 2027–2029.
55. Gibreel A, Kos VN, Keelan M, Trieber CA, Levesque S, Michaud S and Taylor DE, 2005. Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype. Antimicrob Agents Chemother 49 (7), 2753–2759.
56. Gibreel A and Taylor DE, 2006. Macrolide resistance in Campylobacter jejuni and Campylobacter coli. J Antimicrob Chemother 58 (2), 243–255.
57. Gibreel A, Wetsch NM and Taylor DE, 2007. Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni. Antimicrob Agents Chemother 51 (9), 3212–3216.
58. Giguère S. 2006. Antimicrobial drug use in horses. Antimicrobial therapy in veterinary medicine. S. Giguère, J. F. Prescott, J. D. Baggot, R. D. Walker and P. M. Dowling. Blackwell publishing Ltd. 449–462.
59. Gormley FJ, Macrae M, Forbes KJ, Ogden ID, Dallas JF and Strachan NJ, 2008. Has retail chicken played a role in the decline of human campylobacteriosis? Appl Environ Microbiol 74 (2), 383–390.
60. Gradel KO, Nielsen HL, Schonheyder HC, Ejlertsen T, Kristensen B and Nielsen H, 2009. Increased short- and long-term risk of inflammatory bowel disease after Salmonella or Campylobacter gastroenteritis. Gastroenterology.
61. Griggs DJ, Peake L, Johnson MM, Ghori S, Mott A and Piddock LJ, 2009. Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni. Antimicrob Agents Chemother 53 (8), 3357–3364.
62. Guerrant RL, Van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV, Hennessy T, Griffin PM, DuPont H, Sack RB, Tarr P, Neill M, Nachamkin I, Reller LB, Osterholm MT, Bennish ML and Pickering LK, 2001. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 32 (3), 331–351.
63. Gupta A, Fontana J, Crowe C, Bolstorff B, Stout A, Van Duyne S, Hoekstra MP, Whichard JM, Barrett TJ and Angulo FJ, 2003. Emergence of multidrug-resistant Salmonella enterica serotype Newport infections resistant to expanded-spectrum cephalosporins in the United States. J Infect Dis 188 (11), 1707–1716.
64. Hald T, Lo Fo Wong DM and Aarestrup FM, 2008. The attribution of human infections with antimicrobial resistant Salmonella bacteria in Denmark to sources of animal origin. Microbial Drug Resistance 14, 31–35.
65. Hein I, Schneck C, Knogler M, Feierl G, Plesss P, Kofer J, Achmann R and Wagner M, 2003. Campylobacter jejuni isolated from poultry and humans in Styria, Austria: epidemiology and ciprofloxacin resistance. Epidemiol Infect 130 (3), 377–386.
66. Helms M, Simonsen J and Molbak K, 2004. Quinolone resistance is associated with increased risk of invasive illness or death during infection with Salmonella serotype Typhimurium. J Infect Dis 190 (9), 1652–1654.
67. Helms M, Simonsen J and Molbak K, 2006. Foodborne bacterial infection and hospitalization: a registry-based study. Clin Infect Dis 42 (4), 498–506.
68. Helms M, Simonsen J, Olsen KE and Molbak K, 2005. Adverse health events associated with antimicrobial drug resistance in Campylobacter species: a registry-based cohort study. J Infect Dis 191 (7), 1050–1055.
69. Helms M, Vastrup P, Gerner-Smidt P and Molbak K, 2002. Excess mortality associated with antimicrobial drug-resistant Salmonella typhimurium. Emerg Infect Dis 8 (5), 490–495.
70. Heuer OE, Hammerum AM, Collignon P and Wegener HC, 2006. Human health hazard from antimicrobial-resistant enterococci in animals and food. Clin Infect Dis 43 (7), 911–916.
71. Holmberg SD, Wells JG and Cohen ML, 1984. Animal-to-man transmission of antimicrobial-resistant Salmonella: investigations of U.S. outbreaks, 1971–1983. Science 225 (4664), 833–835.
72. Hong J, Kim JM, Jung WK, Kim SH, Bae W, Koo HC, Gil J, Kim M, Ser J and Park YH, 2007. Prevalence and antibiotic resistance of Campylobacter spp. isolated from chicken meat, pork, and beef in Korea, from 2001 to 2006. J Food Prot 70 (4), 860–866.
73. Hopkins KL, Day M and Threlfall EJ, 2008. Plasmid-mediated quinolone resistance in Salmonella enterica, United Kingdom. Emerg Infect Dis 14 (2), 340–342.
74. Hopkins KL, Wootton L, Day MR and Threlfall EJ, 2007. Plasmid-mediated quinolone resistance determinant qnrS1 found in Salmonella enterica strains isolated in the UK. J Antimicrob Chemother 59 (6), 1071–1075.
75. Horrocks SM, Anderson RC, Nisbet DJ and Ricke SC, 2009. Incidence and ecology of Campylobacter jejuni and coli in animals. Anaerobe 15 (1–2), 18–25.
76. HPA International surveillance network for the enteric infections Salmonella and VTEC O157. www.hpa.org.uk/webw/HPAweb&Page&HPAwebAutoListName/Page/1204792008536.
77. Hurd HS and Malladi S. 2008. A stochastic assessment of the public health risks of the use of macrolide antibiotics in food animals. Risk Anal 28(3), 695–710.
78. Johnson JY, McMullen LM, Hasselback P, Louie M, Jhangri G and Saunders LD, 2008. Risk factors for ciprofloxacin resistance in reported Campylobacter infections in southern Alberta. Epidemiol Infect 136 (7), 903–912.
79. Jones YE, Chappell S, McLaren IM, Davies RH and Wray C, 2002. Antimicrobial resistance in Salmonella isolated from animals and their environment in England and Wales from 1988 to 1999. Vet Rec 150 (21), 649–654.
80. Karatzas KA, Webber MA, Jorgensen F, Woodward MJ, Piddock LJ and Humphrey TJ, 2007. Prolonged treatment of Salmonella enterica serovar Typhimurium with commercial disinfectants selects for multiple antibiotic resistance, increased efflux and reduced invasiveness. J Antimicrob Chemother 60 (5), 947–955.
81. Kassenborg HD, Smith KE, Vugia DJ, Rabatsky-Ehr T, Bates MR, Carter MA, Dumas NB, Cassidy MP, Marano N, Tauxe RV and Angulo FJ, 2004. Fluoroquinolone-resistant Campylobacter infections: eating poultry outside of the home and foreign travel are risk factors. Clin Infect Dis 38 Suppl 3, S279–284.
82. Kehrenberg C, Friederichs S, de Jong A, Michael GB and Schwarz S, 2006. Identification of the plasmid-borne quinolone resistance gene qnrS in Salmonella enterica serovar Infantis. J Antimicrob Chemother 58 (1), 18–22.
83. Kollef MH, 2003. The importance of appropriate initial antibiotic therapy for hospital-acquired infections. The American Journal of Medicine 115 (7), 582–584.
84. Lester CH, Frimodt-Moller N, Sorensen TL, Monnet DL and Hammerum AM, 2006. In vivo transfer of the vanA resistance gene from an Enterococcus faecium isolate of animal origin to an E. faecium isolate of human origin in the intestines of human volunteers. Antimicrob Agents Chemother 50 (2), 596–599.
85. Levesque S, Frost E and Michaud S, 2007. Comparison of antimicrobial resistance of Campylobacter jejuni isolated from humans, chickens, raw milk, and environmental water in Quebec. J Food Prot 70 (3), 729–735.
86. Levings RS, Lightfoot D, Hall RM and Djordjevic SP, 2006. Aquariums as reservoirs for multidrug-resistant Salmonella Paratyphi B. Emerg Infect Dis 12 (3), 507–510.
87. Lin CC, Chen TH, Wang YC, Chang CC, Hsuan SL, Chang YC and Yeh KS, 2009. Analysis of ciprofloxacin-resistant Salmonella strains from swine, chicken, and their carcasses in Taiwan and detection of parC resistance mutations by a mismatch amplification mutation assay PCR. J Food Prot 72 (1), 14–20.
88. Little CL, Richardson JF, Owen RJ, de Pinna E and Threlfall EJ, 2008a. Campylobacter and Salmonella in raw red meats in the United Kingdom: prevalence, characterization and antimicrobial resistance pattern, 2003–2005. Food Microbiol 25 (3), 538–543.
89. Little CL, Richardson JF, Owen RJ, de Pinna E and Threlfall EJ, 2008b. Prevalence, characterisation and antimicrobial resistance of Campylobacter and Salmonella in raw poultrymeat in the UK, 2003–2005. Int J Environ Health Res 18 (6), 403–414.
90. Little CL, Walsh S, Hucklesby L, Surman-Lee S, Pathak K, Gatty Y, Greenwood M, de Pinna E, Threlfall EJ, Maund A and Chan CH, 2007. Survey of Salmonella contamination of non-United Kingdom-produced raw shell eggs on retail sale in the northwest of England and London, 2005 to 2006. J Food Prot 70 (10), 2259–2265.
91. Livermore DM and Woodford N, 2006. The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol 14 (9), 413–420.
92. Lodise Thomas P, McKinnon Peggy S, Swiderski L and Rybak Michael J, 2003. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clinical Infectious Diseases 36 (11), 1418–1423.
93. Luangtongkum T, Jeon B, Han J, Plummer P, Logue CM and Zhang Q, 2009. Antibiotic resistance in Campylobacter: emergence, transmission and persistence. Future Microbiol 4 (2), 189–200.
94. Lucey B, Cryan B, O'Halloran F, Wall PG, Buckley T and Fanning S, 2002. Trends in antimicrobial susceptibility among isolates of Campylobacter species in Ireland and the emergence of resistance to ciprofloxacin. Vet Rec 151 (11), 317–320.
95. Mamelli L, Prouzet-Mauleon V, Pagès JM, Megraud F and Bolla JM. 2005. Molecular basis of macrolide resistance in Campylobacter: role of efflux pumps and target mutations. J Antimicrobial Chemother 56, 491–497.
96. Mamelli L, Demoulin E, Prouzet-Mauleon V, Megraud F, Pagès JM, and Bolla JM. 2007. Prevalence of efflux activity in low-level macrolide resistant Campylobacter species. J Antimicrobial Chemother 59, 327–328.
97. MARAN (2007). Monitoring of antimicrobial resistance and antibiotic usage in animals in The Netherlands. www.cvi.wur.nl.
98. Martin LJ, Fyfe M, Dore K, Buxton JA, Pollari F, Henry B, Middleton D, Ahmed R, Jamieson F, Ciebin B, McEwen SA and Wilson JB, 2004. Increased burden of illness associated with antimicrobial-resistant Salmonella enterica serotype typhimurium infections. J Infect Dis 189 (3), 377–384.
99. McGill K, Cowley D, Moran L, Scates P, O'Leary A, Madden RH, Carroll C, McNamara E, Moore JE, Fanning S, Collins JD and Whyte P, 2006. Antibiotic resistance of retail food and human Campylobacter isolates on the island of Ireland from 2001–2002. Epidemiol Infect 134 (6), 1282–1291.
100. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, Griffin PM and Tauxe RV, 1999. Food-related illness and death in the United States. Emerg Infect Dis 5 (5), 607–625.
101. Meakins S, Fisher IS, Berghold C, Gerner-Smidt P, Tschape H, Cormican M, Luzzi I, Schneider F, Wannett W, Coia J, Echeita A and Threlfall EJ, 2008. Antimicrobial drug resistance in human nontyphoidal Salmonella isolates in Europe 2000–2004: a report from the Enter-net International Surveillance Network. Microb Drug Resist 14 (1), 31–35.
102. Miriagou V, Tzouvelekis LS, Rossiter S, Tzelepi E, Angulo FJ and Whichard JM, 2003. Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrob Agents Chemother 47 (4), 1297–1300.
103. Molbak K, 2005. Human health consequences of antimicrobial drug-resistant Salmonella and other foodborne pathogens. Clin Infect Dis 41 (11), 1613–1620.
104. Molbak K, Baggesen DL, Aarestrup FM, Ebbesen JM, Engberg J, Frydendahl K, Gerner-Smidt P, Petersen AM and Wegener HC, 1999. An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype Typhimurium DT104. N Engl J Med 341 (19), 1420–1425.
105. Murray A, Mather H, Coia JE and Brown DJ, 2008. Plasmid-mediated quinolone resistance in nalidixic-acid-susceptible strains of Salmonella enterica isolated in Scotland. J Antimicrob Chemother 62 (5), 1153–1155.
106. Murray CJ and Lopez AD, 1997. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349 (9063), 1436–1442.
107. Nachamkin I, Allos BM and Ho T, 1998. Campylobacter species and Guillain-Barre syndrome. Clin Microbiol Rev 11 (3), 555–567.
108. Nagano K and Nikaido H. Kinetic behavior of the major multidrug efflux pump AcrB of Escherichia coli. Proc Natl Acad Sci U S A. 2009 106(14), 5854–8.
109. Nannapaneni R, Hanning I, Wiggins KC, Story RP, Ricke SC and Johnson MG, 2009. Ciprofloxacin-resistant Campylobacter persists in raw retail chicken after the fluoroquinolone ban. Food Additives & Contaminants: Part A 26 (10), 1348–1353.
110. NARMS (2006). National Antimicrobial Resistance Monitoring System-Enteric Bacteria (NARMS) 2006 Annual Report. Available at: www.cdc.gov/narms/annual/2006/NARMSAnnualReport2006.pdf.
111. Nelson JM, Smith KE, Vugia DJ, Rabatsky-Ehr T, Segler SD, Kassenborg HD, Zansky SM, Joyce K, Marano N, Hoekstra RM and Angulo FJ, 2004. Prolonged diarrhea due to ciprofloxacin-resistant Campylobacter infection. J Infect Dis 190 (6), 1150–1157.
112. Noble WC, Virani Z and Cree RG, 1992. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 72 (2), 195–198.
113. Nollet N, Houf K, Dewulf J, Catry B, de Zutter L, de Kruif A and Maes D, 2006. Variability in antimicrobial resistance among Salmonella enterica strains from fattening pigs and sows. Microb Drug Resist 12 (1), 74–81.
114. Norstrom M, Hofshagen M, Stavnes T, Schau J, Lassen J and Kruse H, 2006. Antimicrobial resistance in Campylobacter jejuni from humans and broilers in Norway. Epidemiol Infect 134 (1), 127–130.
115. O'Brien S, Gillespie I, Charlett A, Adak B, Threlfall EJ and Ward LR, 2004. National case-conttrol study of Salmonella Enteritidis phage type 14B infections in England and wales implicates eggs used in the catering trade. Eurosurveillance 9, 50.
116. O'Regan E, Quinn T, Pagès JM, McCusker M, Piddock L, Fanning S, 2009. Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar Enteritidis: involvement of RamA and other global regulators. Antimicrob Agents Chemother Mar; 53(3):1080–7.
117. O'Regan E, Quinn T, Frye JG, Pagès JM, Porwollik S, Fedorka-Cray PJ, McClelland M, Fanning S, 2010. Fitness costs and stability of a high-level ciprofloxacin resistance phenotype in Salmonella enterica serotype Enteritidis: reduced infectivity associated with decreased expression of spi-1 genes. Antimicrob Agents Chemother, In Press.
118. Pacanowski J, Lalande V, Lacombe K, Boudraa C, Lesprit P, Legrand P, Trystram D, Kassis N, Arlet G, Mainardi JL, Doucet-Populaire F, Girard PM and Meynard JL, 2008. Campylobacter bacteremia: clinical features and factors associated with fatal outcome. Clin Infect Dis 47 (6), 790–796.
119. Pages JM, James CE and Winterhalter M, 2008. The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria. Nat Rev Microbiol 6 (12), 893–903.
120. Pages JM, Lavigne JP, Leflon-Guibout V, Marcon E, Bert F, Noussair L and Nicolas-Chanoine MH, 2009. Efflux pump, the masked side of beta-lactam resistance in Klebsiella pneumoniae clinical isolates. PLoS One 4 (3), e4817.
121. Parisi A, Lanzilotta SG, Addante N, Normanno G, Di Modugno G, Dambrosio A and Montagna CO, 2007. Prevalence, molecular characterization and antimicrobial resistance of thermophilic campylobacter isolates from cattle, hens, broilers and broiler meat in south-eastern Italy. Vet Res Commun 31 (1), 113–123.
122. Payot S, Bolla JM, Corcoran D, Fanning S, Megraud F and Zhang Q, 2006. Mechanisms of fluoroquinolone and macrolide resistance in Campylobacter spp. Microbes Infect 8 (7), 1967–1971.
123. Peyrat MB, Soumet C, Maris P and Sanders P, 2008. Recovery of Campylobacter jejuni from surfaces of poultry slaughterhouses after cleaning and disinfection procedures: analysis of a potential source of carcass contamination. Int J Food Microbiol 124 (2), 188–194.
124. Pitout JD, Reisbig MD, Mulvey M, Chui L, Louie M, Crowe L, Church DL, Elsayed S, Gregson D, Ahmed R, Tilley P and Hanson ND, 2003. Association between handling of pet treats and infection with Salmonella enterica serotype newport expressing the AmpC beta-lactamase, CMY-2. J Clin Microbiol 41 (10), 4578–4582.
125. Poutrel B, Stegemann MR, Roy O, Pothier F, Tilt N and Payne-Johnson M, 2008. Evaluation of the efficacy of systemic danofloxacin in the treatment of induced acute Escherichia coli bovine mastitis. J Dairy Res 75 (3), 310–318.
126. Prescott JF, Baggot JD and Walker RD. 2000. Antimicrobial therapy in veterinary medicine. Ames, Iowa, Iowa State University Press.
127. Price LB, Lackey LG, Vailes R and Silbergeld E, 2007. The persistence of fluoroquinolone-resistant Campylobacter in poultry production. Environ Health Perspect 115 (7), 1035–1039.
128. Quinn T, Bolla JM, Pages JM and Fanning S, 2007. Antibiotic-resistant Campylobacter: could efflux pump inhibitors control infection? J Antimicrob Chemother 59 (6), 1230–1236.
129. Quinn T, O'Mahony R, Baird AW, Drudy D, Whyte P and Fanning S, 2006. Multi-drug resistance in Salmonella enterica: efflux mechanisms and their relationships with the development of chromosomal resistance gene clusters. Curr Drug Targets 7 (7), 849–860.
130. Randall LP, Bagnall MC, Karatzas KA, Coldham NC, Piddock LJ and Woodward MJ, 2008. Fitness and dissemination of disinfectant-selected multiple-antibiotic-resistant (MAR) strains of Salmonella enterica serovar Typhimurium in chickens. J Antimicrob Chemother 61 (1), 156–162.
131. Randall LP, Clouting CS, Gradel KO, Clifton-Hadley FA, Davies RD and Woodward MJ, 2005. Farm disinfectants select for cyclohexane resistance, a marker of multiple antibiotic resistance, in Escherichia coli. J Appl Microbiol 98 (3), 556–563.
132. Randall LP, Cooles SW, Sayers AR and Woodward MJ, 2001. Association between cyclohexane resistance in Salmonella of different serovars and increased resistance to multiple antibiotics, disinfectants and dyes. J Med Microbiol 50 (10), 919–924.
133. Rantala M, Kaartinen L, Valimaki E, Stryrman M, Hiekkaranta M, Niemi A, Saari L and Pyorala S, 2002. Efficacy and pharmacokinetics of enrofloxacin and flunixin meglumine for treatment of cows with experimentally induced Escherichia coli mastitis. J Vet Pharmacol Ther 25 (4), 251–258.
134. Riano I, Garcia-Campello M, Saenz Y, Alvarez P, Vinue L, Lantero M, Moreno MA, Zarazaga M and Torres C, 2009. Occurrence of extended-spectrum beta-lactamase-producing Salmonella enterica in northern Spain with evidence of CTX-M-9 clonal spread among animals and humans. Clin Microbiol Infect 15 (3), 292–295.
135. Rodriguez I, Barownick W, Helmuth R, Mendoza MC, Rodicio MR, Schroeter A and Guerra B, 2009. Extended-spectrum {beta}-lactamases and AmpC {beta}-lactamases in ceftiofur-resistant Salmonella enterica isolates from food and livestock obtained in Germany during 2003–07. J Antimicrob Chemother 64 (2), 301–309.
136. Rosengren LB, Waldner CL, Reid-Smith RJ and Valdivieso-Garcia A, 2009. Associations between antimicrobial exposure and resistance in fecal Campylobacter spp. from grow-finish pigs on-farm in Alberta and Saskatchewan, Canada. J Food Prot 72 (3), 482–489.
137. Rozynek E, Dzierzanowska-Fangrat K, Korsak D, Konieczny P, Wardak S, Szych J, Jarosz M and Dzierzanowska D, 2008. Comparison of antimicrobial resistance of Campylobacter jejuni and Campylobacter coli isolated from humans and chicken carcasses in Poland. J Food Prot 71 (3), 602–607.
138. Sato Y, Mori T, Koyama T and Nagase H, 2000. Salmonella Virchow infection in an infant transmitted by household dogs. J Vet Med Sci 62 (7), 767–769.
139. SCENIHR, 2009. Scientific Committee on Emerging and Newly Identified Health Risks Opinion on: Assessment of the Antibiotic Resistance Effects of Biocides. ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_021.pdf.
140. SCHER/SCENIHR, 2008. Scientific opinion on the environmental impact and effect on antimicrobial resistance of four substances used for the removal of microbial surface contamination on poultry carcases. ec.europa.eu/health/ph_risk/committees/04_scher/docs/scher_o_081.pdf.
141. Shpigel NY, Levin D, Winkler M, Saran A, Ziv G and Bottner A, 1997. Efficacy of cefquinome for treatment of cows with mastitis experimentally induced using Escherichia coli. J Dairy Sci 80 (2), 318–323.
142. Skanseng B, Trosvik P, Zimonja M, Johnsen G, Bjerrum L, Pedersen K, Wallin N and Rudi K, 2007. Co-infection dynamics of a major food-borne zoonotic pathogen in chicken. PLoS Pathog 3 (11), e175.
143. Smith KE, Besser JM, Hedberg CW, Leano FT, Bender JB, Wicklund JH, Johnson BP, Moore KA, Osterholm MT and The Investigation T, 1999. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992–1998. N Engl J Med 340 (20), 1525–1532.
144. Soonthornchaikul N and Garelick H, 2009. Antimicrobial resistance of Campylobacter species isolated from edible bivalve molluscs purchased from Bangkok markets, Thailand. Foodborne Pathog Dis.
145. Streit JM, Jones RN, Toleman MA, Stratchounski LS and Fritsche TR, 2006. Prevalence and antimicrobial susceptibility patterns among gastroenteritis-causing pathogens recovered in Europe and Latin America and Salmonella isolates recovered from bloodstream infections in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (2003). Int J Antimicrob Agents 27 (5), 367–375.
146. Swanson SJ, Snider C, Braden CR, Boxrud D, Wunschmann A, Rudroff JA, Lockett J and Smith KE, 2007. Multidrug-resistant Salmonella enterica serotype Typhimurium associated with pet rodents. N Engl J Med 356 (1), 21–28.
147. Tenkate TD and Stafford RJ, 2001. Risk factors for Campylobacter infection in infants and young children: a matched case-control study. Epidemiol Infect 127 (3), 399–404.
148. Tenson T, Lovmar M and Ehrenberg M, 2003. The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome. J Mol Biol 330 (5), 1005–1014.
149. Threlfall EJ, 2000. Epidemic Salmonella Typhimurium DT 104–a truly international multiresistant clone. J Antimicrob Chemother 46 (1), 7–10.
150. Threlfall EJ, Day M, de Pinna E, Charlett A and Goodyear KL, 2006. Assessment of factors contributing to changes in the incidence of antimicrobial drug resistance in Salmonella enterica serotypes Enteritidis and Typhimurium from humans in England and Wales in 2000, 2002 and 2004. Int J Antimicrob Agents 28 (5), 389–395.
151. Threlfall EJ, Ward LR, Frost JA, Cheasty T and Willshaw GA, 1999. The emergence and spread of antibiotic resistance in food-borne bacteria in the United Kingdom. AUPA Newsletter 17, 1–7.
152. Travers K and Barza M, 2002. Morbidity of infections caused by antimicrobial-resistant bacteria. Clin Infect Dis 34 Suppl 3, S131–134.
153. Van den Brandhof WE, de Wit GA, de Wit MA and Van Duynhoven YT, 2004. Costs of gastroenteritis in The Netherlands. Epidemiol Infect 132 (2), 211–221.
154. Varma JK, Marcus R, Stenzel SA, Hanna SS, Gettner S, Anderson BJ, Hayes T, Shiferaw B, Crume TL, Joyce K, Fullerton KE, Voetsch AC and Angulo FJ, 2006. Highly resistant Salmonella Newport-MDRAmpC transmitted through the domestic US food supply: a FoodNet case-control study of sporadic Salmonella Newport infections, 2002–2003. J Infect Dis 194 (2), 222–230.
155. Varma JK, Molbak K, Barrett TJ, Beebe JL, Jones TF, Rabatsky-Ehr T, Smith KE, Vugia DJ, Chang HG and Angulo FJ, 2005. Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. J Infect Dis 191 (4), 554–561.
156. Veldman K, Van Pelt W and Mevius D, 2008. First report of qnr genes in Salmonella in The Netherlands. J Antimicrob Chemother 61 (2), 452–453.
157. Walker RA, Lawson AJ, Lindsay EA, Ward LR, Wright PA, Bolton FJ, Wareing DR, Corkish JD, Davies RH and Threlfall EJ, 2000. Decreased susceptibility to ciprofloxacin in outbreak-associated multiresistant Salmonella Typhimurium DT104. Vet Rec 147 (14), 395–396.
158. Wassenaar TM, Kist M, de Jong A. 2007. Re-analysis of the risks attributed to ciprofloxacin-resistant Campylobacter jejuni infections. Int J Antimicrob Agents 30 (3):195–201.
159. Weese JS, Baptiste KE, Baverud V and Toutain PL. 2008. Guidelines for antimicrobial use in horses. Guide to antimicrobial use in animals. L. Guardabassi, L. B. Jensen and H. Kruse. Blackwell publishing ltd. 161–182.
160. Whichard JM, Gay K, Stevenson JE, Joyce KJ, Cooper KL, Omondi M, Medalla F, Jacoby GA and Barrett TJ, 2007. Human Salmonella and concurrent decreased susceptibility to quinolones and extended-spectrum cephalosporins. Emerg Infect Dis 13 (11), 1681–1688.
161. WHO (2007). Report of the Second WHO Expert Meeting: Critically important antimicrobials for human medicine: Categorization for the development of risk management strategies to contain antimicrobial resistance due to non-human antimicrobial use www.who.int/foodborne_disease/resistance/antimicrobials_human.pdf.
162. Yamane K, Wachino J, Suzuki S, Kimura K, Shibata N, Kato H, Shibayama K, Konda T and Arakawa Y, 2007. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob Agents Chemother 51 (9), 3354–3360.
163. Yu EW, McDermott G, Zgurskaya HI, Nikaido H and Koshland DE, Jr., 2003. Structural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump. Science 300 (5621), 976–980.